Results 261 to 270 of about 376,147 (348)
Intracellular Catalytic Photooxygenation of α‐Synuclein Amyloid
Amyloid‐selective catalytic photooxygenation reduces amyloid toxicity, aggregation tendencies, and seeding activities. Achieving therapeutic catalysis for intracellular amyloids is challenging due to conflicting oxygenation and reductive cellular environments.
Atsushi Iwai +11 more
wiley +1 more source
Cerebellar White Matter Microstructure Is Associated With Age, Cerebrospinal Fluid Amyloid Beta Levels, and Cognition in Cognitively Unimpaired Older Adults. [PDF]
Paitel ER +8 more
europepmc +1 more source
HXE modulates Cu(Aβ) interaction, reducing ROS production and shifting peptide aggregation in the presence of Cu from toxic amorphous aggregates to less harmful fibrillar structures. These findings highlight HXE potential to interfere with Cu‐induced oxidative stress and aggregation pathways relevant to AD.
Barbara Marinho Barbosa +9 more
wiley +1 more source
In Situ Observation of Polyoxometalate Formation by Vibrational Spectroscopy
In‐situ IR and Raman spectroscopy were employed to observe the formation of polyoxometalates (POMs) in aqueous solution. Thereby key intermediates were identified, and better understanding of POM formation enabled the development of an improved method for the synthesis of vanadium‐substituted phosphomolybdates, which are important catalysts for ...
Jan‐Dominik H. Krueger +5 more
wiley +1 more source
Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer's Disease. [PDF]
Pokrzyk J +4 more
europepmc +1 more source
Green chemistry‐based late‐stage functionalization (LSF) of the anti‐proprotein convertase subtilisin/kexin type 9 (PCSK9) early lead compound 5c led to optimized analogs with improved metabolic stability/PCSK9 IC50 ratio. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key drug target for the treatment of different hypercholesterolemia ...
Lisa Giannessi +12 more
wiley +1 more source
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations. [PDF]
McVea A +24 more
europepmc +1 more source

